Shares of EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) dropped 0.3% during mid-day trading on Thursday . The company traded as low as $0.10 and last traded at $0.15. Approximately 605 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 9,457 shares. The stock had previously closed at $0.16.
EOM Pharmaceuticals Trading Down 0.3 %
The firm has a fifty day moving average of $0.15 and a 200 day moving average of $0.15.
EOM Pharmaceuticals Company Profile
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Read More
- Five stocks we like better than EOM Pharmaceuticals
- What is a Stock Market Index and How Do You Use Them?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Insider Trades May Not Tell You What You Think
- Top 3 Beverage Stocks Pouring Out Profits
- Financial Services Stocks Investing
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
